Zdori, Semmelweis University, Hungary Updates Copyright 2021 Seiwerth, Milavic, Vukojevic, Gojkovic, Krezic, Vuletic, Pavlov, Petrovic, Sikiric, Vranes, Prtoric, Zizek, Durasin, Dobric, Staresinic, Strbe, Knezevic, Sola, Kokot, Sever, Lovric, Skrtic, Blagaic and Sikiric
Direction of Future Research A multicenter randomized clinical trial is current in progress in Spain primary health-care setting called Project OB12 ( Conclusion Oral vitamin B12 replacement at 1000 g daily is an adequate alternative to IM B12 injections
Licensed compounding pharmacies may be able to once again operate within a defined regulatory framework to prepare these peptides, bringing them back into a setting where quality, oversight, and traceability are central.[6] Patients can access therapies within a system designed to protect them
One pound